Haleon boosts US sales by targeting consumers on weight-loss drugs
Consumer health company Haleon has achieved growing sales of products to counter side-effects of weight-loss drugs in the US, the company said, capitalising on the rising popularity of GLP-1 medication
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.timeslive.co.za — the content belongs to TimesLIVE.
